when did semaglutide come on the market Size, Share & Growth Report, 2035 The Wegovy Pill Is Here:

Managing blood sugar is essential as we age

Asia-Pacific Glucagon-Like Peptide 1 (GLP-1) Agonists Market Insight The Asia-Pacific Glucagon-Like Peptide 1 (GLP-1) Agonists market is expected to witness rapid growth and is projected to register the fastest CAGR of 9.4% from 2026 to 2033 , driven by the rapidly expanding diabetic population, rising obesity prevalence, and increasing healthcare expenditure across countries such as China, India, Japan, and South Korea

This product is intended strictly for research and laboratory use only

Fluctuations in it can lead to various severe health issues including heart disease 1 , damage to blood vessels, kidney disease, obesity, diabetic ketoacidosis, and hypertension